RetinalGenix Technologies RTGN
OTC RTGN
$3.99 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

RetinalGenix Technologies (RTGN) Cash from Financing Activities (2020 - 2026)

Updated

RetinalGenix Technologies (RTGN) recorded Cash from Financing Activities of $163,723 in Q2 2026, up 20.2% from $136,200 a year earlier and up 73.0% from the prior quarter.

Analysis

RetinalGenix Technologies (RTGN) Cash from Financing Activities (2020 - 2026) Analysis & Trends

On a TTM basis, RetinalGenix Technologies' Cash from Financing Activities came in at $504,333 as of Jun 30, 2026, down 25.1% year-over-year; for FY2025, it came in at $567,064, down 24.2% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $747,996 in FY2024 (+65.6%), $451,623 in FY2023 (+132.0%), $194,685 in FY2022 (-83.4%) and $1.17 million in FY2021 (-14.6%).
  • The Q2 2026 figure is the highest quarterly Cash from Financing Activities since Q1 2025.
  • On a year-over-year basis, Cash from Financing Activities rose in two of the last seven quarters, with an average decline of 22.7%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 878.0% in Q4 2023, against a decline of 97.1% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $94,619 (Q1 2026), $142,901 (Q4 2025) and $103,090 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -1.57 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -3.52 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.27 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -287.90 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -343.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -95.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -410.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -300,000.00
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -577.00 Mn
10 RetinalGenix Technologies 75.19 Mn 75.14 Mn - 163,723.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 163,723.00
Mar 31, 2026 94,619.00
Dec 31, 2025 142,901.00
Sep 30, 2025 103,090.00
Jun 30, 2025 136,200.00
Mar 31, 2025 184,873.00
Dec 31, 2024 113,361.00
Sep 30, 2024 239,108.00
Jun 30, 2024 181,322.00
Mar 31, 2024 214,205.00
Dec 31, 2023 289,981.00
Sep 30, 2023 -41,618.00
Jun 30, 2023 118,253.00
Mar 31, 2023 85,007.00
Dec 31, 2022 29,651.00
Sep 30, 2022 62,848.00
Jun 30, 2022 7,786.00
Mar 31, 2022 94,400.00
Dec 31, 2021 258,934.00
Sep 30, 2021 248,000.00
API Access

RetinalGenix Technologies Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RTGN&period=max&api_key=YOUR_API_KEY